We use cookies to personalise the web experience for you. By using www.helgilibrary.com, you agree to our use of cookies.
Some cookies are also used by Google Analytics, which anonymously tracks visitors and helps us to analyse how users use our website. Read more

PHOENIX Lekarensky Velkoobchod

Retail & Wholesale > Czech Republic > PHOENIX Lekarensky Velkoobchod
Change Company
PHOENIX Lekarensky Velkoobchod

Phoenix Lekárenský Velkoobchod, a.s. is a Czech Republic-based pharmaceutical distributor. With a market share of nearly 40%, the Company is clearly the leader on the Czech wholesale pharmaceutical market. The Company operates six warehouses throughout the Czech Republic (Praha, Brno, Ostrava, Plzeň, Vysoké Mýto, Ševětín). The Company supplies pharmacies and hospitals with pharmaceutical

Read more »
Phoenix Lekárenský Velkoobchod, a.s. is a Czech Republic-based pharmaceutical distributor. With a market share of nearly 40%, the Company is clearly the leader on the Czech wholesale pharmaceutical market. The Company operates six warehouses throughout the Czech Republic (Praha, Brno, Ostrava, Plzeň, Vysoké Mýto, Ševětín). The Company supplies pharmacies and hospitals with pharmaceutical products, offers warehouse services to pharmaceutical producers and runs a network of its own pharmacies through its subsidiary BENU Česká republika. Phoenix Lekarensky Velkoobchod operates as a subsidiary of PHOENIX Pharmahandel Aktiengesellschaft & Co. KG.

Buy all financials of PHOENIX Lekarensky Velkoobchod

from $199 /month

Buy annual subscriptions for all our products.

summary Unit
2009 2010 2011 2012 2013 2014 2015 2016 2017

income statement

Sales CZK mil
Gross Profit CZK mil
EBIT CZK mil
Net Profit CZK mil
ROE %
EBIT Margin %
Net Margin %
Employees
    25,001 23,934 22,866 23,289 22,946    
    745 728 715 725 702    
    365 359 364 351 295    
    209 216 220 185 139    
    8.85% 9.84% 9.70% 8.13% 6.37%    
    1.46% 1.50% 1.59% 1.51% 1.28%    
    0.836% 0.901% 0.961% 0.793% 0.607%    
    666 668 675 709 ...    

balance sheet

    9,041 8,501 9,525 8,884 8,990    
    2,542 2,504 2,522 2,537 2,605    
    6,495 5,991 7,004 6,343 6,381    
    2,156 2,229 2,301 2,241 2,134    
    6,885 6,272 7,224 6,642 6,856    
    1,529 17.8 19.9 27.4 27.6    
    5,343 6,244 7,186 6,561 6,798    
    5.16 1.58 2.85 2.23 3.34    
    99.4% 29.2% 49.5% 38.5% 52.1%    
...   4.64% 5.76% 9.27% 11.0% 11.3%    

cash flow

... ... ... ... ... ... ...    
... ... ... ... ... ... ...    
... ... ... ... ... ... ...    
... ... ... ... ... ... ...    

Download Data
income statement Unit
2009 2010 2011 2012 2013 2014 2015 2016 2017

income statement

Sales CZK mil
Cost of Goods & Services CZK mil
Gross Profit CZK mil
Staff Cost CZK mil
Other Cost CZK mil
EBITDA CZK mil
Depreciation CZK mil
EBIT CZK mil
Financing Cost CZK mil
Extraordinary Cost CZK mil
Pre-Tax Profit CZK mil
Tax CZK mil
Minorities CZK mil
Net Profit CZK mil
Dividends CZK mil
    25,001 23,934 22,866 23,289 22,946    
    24,256 23,206 22,151 22,564 22,244    
    745 728 715 725 702    
    293 292 294 321 339    
    37.0 25.7 21.4 18.4 30.2    
    415 411 400 386 333    
    50.6 51.2 35.5 35.0 38.4    
    365 359 364 351 295    
    93.4 82.8 89.0 117 121    
    0.000 0.000 -0.351 -0.012 0.000    
    271 277 275 234 174    
    62.4 60.9 55.8 49.1 34.8    
    0.000 0.000 0.000 0.000 0.000    
    209 216 220 185 139    
... ... ... ... ... ... 216   ...

growth rates

...   -2.29% -4.27% -4.46% 1.85% -1.47%    
...   -1.20% -3.69% -0.617% 7.45% 8.79%    
...   -0.568% -1.16% -2.66% -3.39% -13.7%    
...   0.214% -1.49% 1.34% -3.59% -16.0%    
...   -1.42% 1.90% -0.376% -15.1% -25.5%    
...   -0.320% 3.18% 1.89% -15.9% -24.5%    

ratios

    8.85% 9.84% 9.70% 8.13% 6.37%    
...   5.04% 6.47% 8.12% 6.27% 4.30%    
    2.98% 3.04% 3.13% 3.11% 3.06%    
    1.66% 1.72% 1.75% 1.66% 1.45%    
    1.46% 1.50% 1.59% 1.51% 1.28%    
    0.836% 0.901% 0.961% 0.793% 0.607%    
... ... ... ... ... ... 155%   ...
...   4.64% 5.76% 9.27% 11.0% 11.3%    
    5.16 1.58 2.85 2.23 3.34    

Download Data
balance sheet Unit
2009 2010 2011 2012 2013 2014 2015 2016 2017

balance sheet

    2,542 2,504 2,522 2,537 2,605    
    810 791 810 825 894    
    2.96 1.03 1.66 2.28 2.70    
    6,495 5,991 7,004 6,343 6,381    
    1,912 1,817 2,080 1,973 2,096    
    4,140 3,682 3,575 3,705 3,738    
    25.1 59.3 73.3 65.1 87.6    
    9,041 8,501 9,525 8,884 8,990    
    2,156 2,229 2,301 2,241 2,134    
    0.000 0.000 0.000 0.000 0.000    
    6,885 6,272 7,224 6,642 6,856    
    1,529 17.8 19.9 27.4 27.6    
    1,517 1.81 4.07 6.19 0.000    
    11.8 16.0 15.8 21.2 22.8    
    5,343 6,244 7,186 6,561 6,798    
    650 708 1,207 922 1,200    
    4,516 5,411 5,356 5,144 5,034    
    10.2 9.21 7.05 13.6 15.9    
    9,041 8,501 9,525 8,884 8,990    

growth rates

...   -0.015% -5.97% 12.0% -6.74% 1.19%    
...   -16.1% 3.42% 3.23% -2.60% -4.79%    
...   26.1% -69.6% 75.0% -24.2% 29.0%    
...   16.6% -67.3% 70.7% -23.4% 29.4%    

ratios

    2,167 710 1,211 928 1,200    
    2,142 650 1,138 863 1,112    
    1,536 87.3 299 534 800    
    4,078 2,591 2,821 3,070 3,406    
    99.4% 29.2% 49.5% 38.5% 52.1%    
...   4.64% 5.76% 9.27% 11.0% 11.3%    

Download Data
cash flow Unit
2009 2010 2011 2012 2013 2014 2015 2016 2017

cash flow

    209 216 220 185 139    
    50.6 51.2 35.5 35.0 38.4    
... ... ... ... ... ... ...    
... ... ... ... ... ... ...    
... ... ... ... ... ... ...    
... ... ... ... ... ... ...    
... ... ... ... ... ... ...    
... ... ... ... ... ... ...    
... ... ... ... ... ... ...    
... ... ... ... ... ... ...    
... ... ... ... ... ... ...    
... ... ... ... ... ... ...    
... ... ... ... ... ... ...    

ratios

    60.4 56.1 57.1 58.1 59.5    
    28.8 28.6 34.3 31.9 34.4    
    68.0 85.1 88.3 83.2 82.6    
    21.3 -0.388 3.08 6.77 11.3    
    260 267 255 220 178    
... ... ... ... ... ... ...    

Download Data
other data Unit
2009 2010 2011 2012 2013 2014 2015 2016 2017

other data

    2.31% 2.46% 2.44% 2.01% 1.56%    
    2.98% 3.04% 3.13% 3.11% 3.06%    
    666 668 675 709 ...    
    2,071 1,861 1,856 1,764 ...    
    36,632 36,408 36,320 37,703 ...    
    1.19% 1.24% 1.31% 1.40% 1.50%    
    23.0% 22.0% 20.2% 21.0% 20.0%    
... ... 24,903 23,806 22,746 23,159 ... ... ...
... ... ... ... ... ... ...    
... ... 97.9 129 121 130 ... ... ...
... ... 0.392% 0.537% 0.528% 0.559% ... ... ...

Download Data
PHOENIX Lekarensky Velkoobchod in Numbers

This Annual Statistical Dossier offers a summary of PHOENIX Lekarensky Velkoobchod's performance between 2009 and 2017 on an annual basis. The report can be downloaded as an Excel file.

You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.

If you

Read more »

This Annual Statistical Dossier offers a summary of PHOENIX Lekarensky Velkoobchod's performance between 2009 and 2017 on an annual basis. The report can be downloaded as an Excel file.

You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.

If you are only interested in particular areas of the company's business, you can find and download specific indicators from the company's Corporate Profile, or specific charts from the company's Chart Section.

If you are interested in the company’s quarterly figures, please refer to the company’s Quarterly Statistical Dossier.

PHOENIX Lekarensky Velkoobchod made a net profit of CZK 273 mil in 2017, up 5.39% when compared to the last year. Total sales reached CZK 23,446 mil, which is down 2.85% when compared to the previous year.

Historically, the company’s

Read more »

PHOENIX Lekarensky Velkoobchod made a net profit of CZK 273 mil in 2017, up 5.39% when compared to the last year. Total sales reached CZK 23,446 mil, which is down 2.85% when compared to the previous year.

Historically, the company’s net profit reached an all time high of CZK 273 mil in 2017 and an all time low of CZK 139 mil in 2015.

In terms of sales, PHOENIX Lekarensky Velkoobchod reached an all time high of CZK 25,588 mil in 2010 and an all time low of CZK 22,866 mil in 2013.

PHOENIX Lekarensky Velkoobchod's net profit has grown 4.80% a year on average in the last five years while sales have increased by -0.412% a year since 2012.

The firm generated its shareholders an average return on invested capital of 6.17% in the last five years.

As far as PHOENIX Lekarensky Velkoobchod's peers are concerned, Geco posted a net profit and sales of CZK 371 mil and CZK 34,305 mil in 2017 and PEAL generated a net profit of CZK 24.0 mil (with sales of CZK 6,370 mil).

You can see all the company’s data at PHOENIX Lekarensky Velkoobchod Profile, or you can download a report on the company in the report section.

PHOENIX Lekarensky Velkoobchod made a net profit of CZK CZK 273 mil under revenues of CZK 23,446 mil in 2017, up 5.39% and -2.85%, respectively, when compared to the last year.

This translates into a net margin of 1.16%. Historically,

Read more »

PHOENIX Lekarensky Velkoobchod made a net profit of CZK CZK 273 mil under revenues of CZK 23,446 mil in 2017, up 5.39% and -2.85%, respectively, when compared to the last year.

This translates into a net margin of 1.16%. Historically, the firm’s net margin reached an all time high of 1.16% in 2017 and an all time low of 0.607% in 2015. The average net margin in the last five years amounted to 0.919%.

On the operating level, EBITDA margin reached 1.20% and EBIT amounted to 1.42% of sales in 2017.

As far as PHOENIX Lekarensky Velkoobchod's peers are concerned, Geco posted net and EBITDA margin of 1.08% and 1.48%, respectively in 2017 and PEAL generated margins of 0.377% and 0.721%.

You can see all the company’s data at PHOENIX Lekarensky Velkoobchod Profile, or you can download a report on the company in the report section.

PHOENIX Lekarensky Velkoobchod's net debt reached CZK 1,754 mil and accounted for 78.7% of equity at the end of 2017. The ratio is down 2.74% when compared to the previous year.

Historically, the firm’s net debt to equity reached

Read more »

PHOENIX Lekarensky Velkoobchod's net debt reached CZK 1,754 mil and accounted for 78.7% of equity at the end of 2017. The ratio is down 2.74% when compared to the previous year.

Historically, the firm’s net debt to equity reached an all time high of 99.4% in 2011 and an all time low of 29.2% in 2012.

When compared to EBITDA, net debt amounted to 5.29x at the end of the year. The ratio reached an all time high of 5.29 in 2017 and an all time low of 1.58 in 2012.

As far as PHOENIX Lekarensky Velkoobchod's peers are concerned, Geco posted net debt to equity of 47.3%x and 0.592x when compared to EBITDA at the end of 2017. PEAL ended the year 2017 with a net debt at 125%x of equity and 3.56x when compared to its EBITDA while PEAL had net debt at 125%x of equity and 3.56x to EBITDA at the end of the year.

You can see all the company’s data at PHOENIX Lekarensky Velkoobchod Profile, or you can download a report on the company in the report section.

PHOENIX Lekarensky Velkoobchod employed 742 persons in 2017, up 2.20% when compared to the previous year. Historically, the firm's workforce hit an all time high of 755 in 2009 and an all time low of 666 in 2011.

Average cost

Read more »

PHOENIX Lekarensky Velkoobchod employed 742 persons in 2017, up 2.20% when compared to the previous year. Historically, the firm's workforce hit an all time high of 755 in 2009 and an all time low of 666 in 2011.

Average cost reached USD 1,894 per month per employee per month, 14.5% more than a year ago.

As far as PHOENIX Lekarensky Velkoobchod's peers are concerned, Geco employed some 1,708 people in 2017 while PEAL was operating with 523 staff.

You can see all the company’s data at PHOENIX Lekarensky Velkoobchod Profile, or you can download a report on the company in the report section.

See all charts of the company »
PHOENIX's net profit rose 5.39% to CZK 273 mil in 2017
PHOENIX's net profit rose 5.39% to CZK 273 mil in 2017
PHOENIX's employees rose 2.20% to 742 in 2017
PHOENIX's Net Margin rose 8.48% to 1.16% in 2017
PHOENIX's Net Debt/EBITDA rose 8.02% to 5.29 in 2017
PHOENIX's Cash & Cash Equivalents rose 9.61% to CZK 78.7 mil in 2017
PHOENIX's ROCE fell 8.45% to 5.81% in 2017